|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Verastem Bucks the Trend, Raises $55M in IPO
|
Luke Timmerman |
01/26/12 |
Boston
|
|
Acceleron Adds $30M From Partner Celgene and Existing Investors
|
Arlene Weintraub |
12/23/11 |
Boston
|
|
Acceleron Pharma Lands $30,000,000 New Financing
|
VentureDeal |
12/23/11 |
Boston
|
|
Biofuels Firm Coskata, Backed by Boston VCs, Files for IPO
|
Gregory T. Huang |
12/19/11 |
Boston
|
|
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round
|
VentureDeal |
12/13/11 |
Boston
|
|
Qualcomm, uTest, Progress, & Others Inking Boston Deals This Week
|
Erin Kutz |
12/07/11 |
Boston
|
|
Actifio Gets Active With $33.5M Led by Andreessen Horowitz
|
Gregory T. Huang |
12/05/11 |
Boston
|
|
ActiFio Garners $33,500,000 Series C Financing
|
VentureDeal |
12/05/11 |
Boston
|
|
Join Us for a Live “Tweetchat” on the Biotech VC Crisis with Daphne Zohar of PureTech Ventures
|
Luke Timmerman |
11/16/11 |
National
|
|
Hey, Where Is Everybody Going? The Flight from Healthcare Investing
|
Lisa Suennen |
11/14/11 |
San Francisco
|
|
Scale Venture Partners Gives Up On Healthcare & Life Sciences Investing
|
Wade Roush |
11/08/11 |
San Francisco
|
|
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO
|
Luke Timmerman |
11/03/11 |
Boston
|
|
Morgenthaler Ventures, ATV To Merge Life Sciences Teams, Form New Fund
|
Luke Timmerman |
10/31/11 |
San Francisco
|
|
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs
|
Luke Timmerman |
10/27/11 |
San Francisco
|
|
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment
|
Arlene Weintraub |
10/20/11 |
Boston
|
|
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity
|
Arlene Weintraub |
09/14/11 |
Boston
|
|
Valeritas Raises $150M for Insulin Device
|
Arlene Weintraub |
09/13/11 |
New York
|
|
GI Dynamics Raises $85M USD in Aussie IPO
|
Erin Kutz |
08/30/11 |
Boston
|
|
Coskata Lands Series D Funding
|
VentureDeal |
08/22/11 |
Detroit
|
|
Cedexis Lands $6,000,000 Series A Funding Round
|
VentureDeal |
08/16/11 |
Seattle
|
|
Second Genome Pockets $5M to Uncover the Secrets of Bugs, Good and Bad, in Your Gut
|
Luke Timmerman |
08/09/11 |
San Francisco
|
|
Second Genome Garners $5,000,000 Series A Financing Round
|
VentureDeal |
08/09/11 |
San Francisco
|
|
GI Dynamics and Exa File for IPOs in Weight Loss Devices, Automotive Software
|
Gregory T. Huang |
08/04/11 |
Boston
|
|
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News
|
Erin Kutz |
07/20/11 |
Boston
|
|
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News
|
Erin Kutz |
07/15/11 |
Boston
|
|
“Coolsculptor” Zeltiq Plans IPO
|
Wade Roush |
07/14/11 |
San Francisco
|
|
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors
|
Arlene Weintraub |
07/14/11 |
Boston
|
|
Verastem Obtains $32,000,000 Series B Financing Round
|
VentureDeal |
07/14/11 |
Boston
|
|
Report: ATV Trims Staff
|
Gregory T. Huang |
06/13/11 |
Boston
|
|
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/10/11 |
Boston
|
|
Page 1 of
5 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.